Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3765044011 | Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release orodispersible tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3765045012 | Selegiline hydrochloride 1.25 mg orodispersible tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Has manufactured dose form | Orodispersible tablet | true | Inferred relationship | Some | ||
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Has BoSS | Selegiline hydrochloride | true | Inferred relationship | Some | 1 | |
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Has presentation strength numerator value | 1.25 | false | Inferred relationship | Some | 1 | |
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Has precise active ingredient | Selegiline hydrochloride | true | Inferred relationship | Some | 1 | |
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Is a | Selegiline only product in oromucosal dose form | false | Inferred relationship | Some | ||
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Some | ||
| Selegiline hydrochloride 1.25 mg orodispersible tablet | Is a | Selegiline only product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
FHIR